Prelude Therapeutics Inc

NASDAQ:PRLD   3:59:50 PM EDT
14.24
+0.49 (+3.56%)
Earnings Announcements

Prelude Therapeutics Announced Q3 Results

Published: 11/12/2021 14:24 GMT
Prelude Therapeutics Inc (PRLD) - Prelude Therapeutics Announces Third Quarter 2021 Financial Results and Operations Update.
Qtrly Loss per Share $0.66.
Q3 Earnings per Share View $-0.63 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.68

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.76

More details on our Analysts Page.